Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-21

Clinical Trial Update: Efficacy of Adding Dexmedetomidine Versus Ibuprofen as an Adjuvant to Intraperitoneal Bupivacaine for Pain Control After Laparoscopic Gynecological Procedures [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial investigating dexmedetomidine vs ibuprofen as adjuvants to intraperitoneal bupivacaine for pain control after laparoscopic gynecologic procedures…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (Bupivacaine)
  • Dexmedetomidine (Dexmedetomidine)
  • Ibuprofen (IBUPROFEN)

Snippet

Sponsor: Ain Shams University | Conditions: Postoperative Pain, Acute | Phase 2, Phase 3 | Status: UNKNOWN